Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Branco

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Plos Pathogens|July 5, 2022
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate speciesAlyssa C Fears, Brandon J Beddingfield, Nicole R Chirichella, et al.
Microorganisms|April 3, 2021
Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019Jeffrey G Shaffer, John S Schieffelin, Mambu Momoh, et al.
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Analysis of CD8<sup>+</sup> T cell response during the 2013-2016 Ebola epidemic in West AfricaSaori Sakabe, Brian M Sullivan, Jessica N Hartnett, et al.
The Journal of Infectious Diseases|May 22, 2020
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola SequelaeStephanie M LaVergne, Saori Sakabe, Lansana Kanneh, et al.
The Lancet. Microbe|April 20, 2026
Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional studyAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
Nature Communications|February 3, 2025
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP<sub>(1,2)</sub> in a position elevated from the virion membraneKathryn M Hastie, Zhe Li Salie, Zunlong Ke, et al.
Cell|March 18, 2022
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolavirusesJacob C Milligan, Carl W Davis, Xiaoying Yu, et al.
Journal of Virology|April 10, 2020
Identification of Common CD8<sup>+</sup> T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra LeoneSaori Sakabe, Jessica N Hartnett, Nhi Ngo, et al.
The Journal of Infectious Diseases|August 14, 2016
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionMatthew L Boisen, Robert W Cross, Jessica N Hartnett, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Plos Pathogens|July 5, 2022
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate speciesAlyssa C Fears, Brandon J Beddingfield, Nicole R Chirichella, et al.
Microorganisms|April 3, 2021
Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019Jeffrey G Shaffer, John S Schieffelin, Mambu Momoh, et al.
Science Translational Medicine|October 26, 2022
A cocktail of protective antibodies subverts the dense glycan shield of Lassa virusHaoyang Li, Tierra Buck, Michelle Zandonatti, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Analysis of CD8<sup>+</sup> T cell response during the 2013-2016 Ebola epidemic in West AfricaSaori Sakabe, Brian M Sullivan, Jessica N Hartnett, et al.
The Journal of Infectious Diseases|May 22, 2020
Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola SequelaeStephanie M LaVergne, Saori Sakabe, Lansana Kanneh, et al.
The Lancet. Microbe|April 20, 2026
Evaluation of antigen and antibody assays for surveillance of Lassa virus in peri-domestic rodents in southeastern Sierra Leone: a cross-sectional studyAllison R Smither, James Koninga, Franklyn B Kanneh, et al.
Nature Communications|February 3, 2025
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP<sub>(1,2)</sub> in a position elevated from the virion membraneKathryn M Hastie, Zhe Li Salie, Zunlong Ke, et al.
Cell|March 18, 2022
Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolavirusesJacob C Milligan, Carl W Davis, Xiaoying Yu, et al.
Journal of Virology|April 10, 2020
Identification of Common CD8<sup>+</sup> T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra LeoneSaori Sakabe, Jessica N Hartnett, Nhi Ngo, et al.
The Journal of Infectious Diseases|August 14, 2016
Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus InfectionMatthew L Boisen, Robert W Cross, Jessica N Hartnett, et al.
Pageof 18